<DOC>
	<DOCNO>NCT03085381</DOCNO>
	<brief_summary>To evaluate safety primary immunogenicity quadrivalent human papillomavirus ( type 6 , 11 , 16 , 18 ) recombinant vaccine ( hansenula polymorpha ) Chinese female subject age 9-45 year .</brief_summary>
	<brief_title>A Phase I Study Quadrivalent HPV Recombinant Vaccine</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy female , include , 9 45 year age time enrolment Be able provide legal identification sake recruitment Be able understand sign inform consent form prior enrollment subject age 917 year , legal guardian ( ) suppose understand sign inform consent form together Subjects investigator believe comply protocol requirement Subject must pregnant enrollment agree use adequate contraceptive precaution within 7 month n't pregnancy plan Fever axillary temperature &gt; 37.0â„ƒ vaccination Previous vaccination HPV , plan administration/administration vaccine foreseen study protocol within 30 day precede first dose vaccine ; Planned take part clinical research within 7 month participate study Abnormal laboratory test parameter Administration whole blood , plasma immunoglobulin product within 3 month precede first vaccination Interval administration study vaccination attenuate live vaccine le 14 day , vaccine less 10 day History serious allergic disease require medical intervention ( oral throat swelling , difficulty breathing , hypotension shock ) History adverse event vaccine , allergic food drug History epilepsy , seizures convulsion , family history mental illness Subjects immunocompromised diagnosed suffering congenital acquire immunodeficiency , HIV infection , lymphoma , leukemia , systemic lupus erythematosus ( SLE ) , rheumatoid arthritis , juvenile rheumatoid arthritis inflammation ( JRA ) , inflammatory bowel disease autoimmune disease , administration immunosuppressant six month prior first vaccine dose . Asplenia , functional asplenia , circumstance result asplenia splenectomy Subject severe hepatorenal disease , cardiovascular disease , hypertension , diabetes , malignant tumor , kinds infectious disease acute illness , chronic disease acute attack period Medical diagnosis coagulation abnormality ( eg , clot factor deficiency , coagulation disorder , platelet anomaly ) obvious bruise coagulation disorder During menstrual period acute disease period onset Breastfeeding , pregnancy ( include pregnancy test positive ) , plan pregnant within 7 month Abnormal cervical cancer screen subject CIN acuteness wet wart relevant HPV infection past two year Planned moveout local end study leave local long time study period Other unsuitable factor study judge investigator</criteria>
	<gender>Female</gender>
	<minimum_age>9 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>